These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20873469)

  • 1. [Myoclonic epilepsy of Lafora: a case report].
    Rudenskaia GE; Zakharova EIu; Karpin SL; Uchaev DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):11-6. PubMed ID: 20873469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lafora's disease presenting with progressive myoclonus epilepsy].
    Béjot Y; Lemesle-Martin M; Contégal F; Graule-Petot A; Thauvin C; Aubriot-Lorton MH; Moreau T; Giroud M
    Rev Neurol (Paris); 2007 Oct; 163(10):975-8. PubMed ID: 18033035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in lafora progressive myoclonus epilepsy.
    Delgado-Escueta AV
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies].
    Martínez-Bermejo A; López-Martín V; Serratosa JM; Gutiérrez-Molina M; Gómez-Garre P; Arcas J; Tendero A; Roche C; Pérez-Mies B
    Rev Neurol; 2002 Jan 16-31; 34(2):117-20. PubMed ID: 11988905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three patients with lafora disease: different clinical presentations and a novel mutation.
    Poyrazoğlu HG; Karaca E; Per H; Gümüs H; Onay H; Canpolat M; Canöz Ö; Ozkınay F; Kumandas S
    J Child Neurol; 2015 May; 30(6):777-81. PubMed ID: 25015673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of skin biopsy for diagnosis in a case of Lafora disease.
    Rozenova KA; Lehman JS; Grande JP; Fine AL; Wieland CN
    J Cutan Pathol; 2022 Oct; 49(10):885-888. PubMed ID: 35708461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lafora disease with a fatal outcome].
    Krakhmal NV; Vasilchenko DV; Vtorushin SV
    Arkh Patol; 2022; 84(6):61-66. PubMed ID: 36469720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lafora disease: epidemiology, pathophysiology and management.
    Monaghan TS; Delanty N
    CNS Drugs; 2010 Jul; 24(7):549-61. PubMed ID: 20527995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
    Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
    Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laforin and malin deletions in mice produce similar neurologic impairments.
    García-Cabrero AM; Marinas A; Guerrero R; de Córdoba SR; Serratosa JM; Sánchez MP
    J Neuropathol Exp Neurol; 2012 May; 71(5):413-21. PubMed ID: 22487859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora.
    Gómez-Garre P; Gutiérrez-Delicado E; Gómez-Abad C; Morales-Corraliza J; Villanueva VE; Rodríguez de Córdoba S; Larrauri J; Gutiérrez M; Berciano J; Serratosa JM
    Neurology; 2007 Apr; 68(17):1369-73. PubMed ID: 17452581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lafora disease - from pathogenesis to treatment strategies.
    Nitschke F; Ahonen SJ; Nitschke S; Mitra S; Minassian BA
    Nat Rev Neurol; 2018 Oct; 14(10):606-617. PubMed ID: 30143794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic studies in patients with Lafora disease from Pakistan.
    Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
    J Neurol Sci; 2017 Feb; 373():263-267. PubMed ID: 28131202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lafora disease: a case report, pathologic and genetic study.
    Harirchian MH; Shandiz EE; Turnbull J; Minassian BA; Shahsiah R
    Indian J Pathol Microbiol; 2011; 54(2):374-5. PubMed ID: 21623095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset Lafora disease and novel EPM2A mutations: breaking paradigms.
    Jara-Prado A; Ochoa A; Alonso ME; Lima Villeda GA; Fernández-Valverde F; Ruano-Calderón L; Vargas-Cañas S; Durón RM; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Res; 2014 Nov; 108(9):1501-10. PubMed ID: 25246353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epm2a
    Burgos DF; Sciaccaluga M; Worby CA; Zafra-Puerta L; Iglesias-Cabeza N; Sánchez-Martín G; Prontera P; Costa C; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2023 Jun; 181():106119. PubMed ID: 37059210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
    Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
    Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset Lafora body disease.
    Turnbull J; Girard JM; Lohi H; Chan EM; Wang P; Tiberia E; Omer S; Ahmed M; Bennett C; Chakrabarty A; Tyagi A; Liu Y; Pencea N; Zhao X; Scherer SW; Ackerley CA; Minassian BA
    Brain; 2012 Sep; 135(Pt 9):2684-98. PubMed ID: 22961547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.
    Spuch C; Ortolano S; Navarro C
    Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.